Data submission simplified for the same preparation with different strengths.

The data to submit for the KFDA registration will be far simplified if the drug be the same dosage form but different strengths, and the domestic clinical study may be restrictively permissible for the use of reference drugs that are not registered in Korea but only available in the overseas markets.

The KFDA announced the above revised and unified drug registration guidelines on Aug. 4 thro...